Arca
Skip to content
Tools
Tools

Focus Night and Day (Lotrafilcon A) Soft Contact Lenses

Lenses, soft contact, extended wear. PMA P010019, from Alcon Laboratories, Inc. (Fort Worth, TX). Product code LPM, class 3.

As of Nov 19, 2026, P010019 is an FDA PMA held by Alcon Laboratories, Inc., approved on Oct 11, 2001 after 204 days, with 2 recalls tied to it in FDA's recall database.

  • Review time: 204 days
  • Supplements: 83
  • Recalls: 2
  • Cited as a predicate by: 3 devices

What FDA approved

FDA's approval order statement

Approval for the Focus Night and Day (Lotrafilcon A) Soft Contact Lenses for extended wear. The device will be marketed with the following trade names and indications: Focus Night and Day (Lotrafilcon A) Soft Contact Lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes and with up to approximately 1.50 diopters of astigmatism. Focus night and day toric (lotrafilcon a) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia in phakic or aphakic persons with non-diseased eyes with 6.00 diopters (d) or less of astigmatism. Focus night and day progressives (lotrafilcon a) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes…

Pivotal study

The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it
Design
Prospective, randomized, controlled, open-label, multicenter study of FN&D monthly extended wear vs. weekly extended wear control lens, one year
Enrolled
1,395
Where
59 sites, US
Primary endpoint
Proportion of subjects with corneal infiltrates (Grade 3 or infiltrates with overlying fluorescein staining), non-inferiority with 5% margin (annualized rate); no primary effectiveness endpoint specified
Result
Non-inferior: annualized infiltrate rate 6.1%/person-year FN&D (95% CI 4.1-8.2%) vs. 3.3% control (95% CI 1.9-4.7%); p=0.047 rejecting inferiority

Cited as a predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to P010019, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
Aug 14, 2018Z-0609-2020The product may be counterfeit and could have microbial issues.Completed
Aug 1, 2018Z-1821-2020Potentially counterfeit products in/and counterfeit packaging were imported to the U.S.Completed

Supplements

83 supplements to this PMA; the 15 newest
May 29, 2026S087Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Feb 26, 2026S086Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
May 15, 2024S085Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Dec 15, 2023S084Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jul 6, 2022S083Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jan 12, 2022S081Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Sep 28, 2021S080Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Sep 10, 2021S079Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Aug 27, 2021S078Location Change - Manufacturer/Sterilizer/Packager/SupplierNormal 180 Day Track No User Fee
Dec 14, 2020S077Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Mar 19, 2020S076Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jan 22, 2020S075Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Dec 12, 2019S074Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Nov 27, 2019S072Location Change - Manufacturer/Sterilizer/Packager/SupplierNormal 180 Day Track No User Fee
Aug 30, 2019S073Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice

Record

Type
Original PMA
Received
Mar 21, 2001
Review panel
Ophthalmic
Regulation
21 CFR 886.5925

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.